BioSpace News Archive

Business

“Thousands of Jobs” Reportedly on the Block as Novartis Restructures

Novartis announced a global restructuring that will include cutting thousands of jobs. The restructuring is intended to effectively merge two divisions within Novartis into one.

April 12, 2022
·
2 min read
·
Jazmine Colatriano, M.S.
Drug Development

Takeda Touts Positive Pediatric Data in Competitive HAE Space

The trial demonstrated a safety profile in the younger age group as seen in patients 12 and older, with no severe side effects and no one dropping out from adverse events.

April 12, 2022
·
2 min read
·
Mark Terry
Business

Aurion Biotech Pots $120M to Advance Cell Therapy for Eye Diseases

The funding will be used to push forward Aurion’s cell therapy program for corneal edema secondary to endothelial dysfunction.

April 12, 2022
·
2 min read
·
Vanessa Doctor, RN
Drug Development

Aeglea Presents Robust Data in Rare Metabolic Disorder, Submits First BLA

As Aeglea presents the data this week at the Society for Inherited Metabolic Disorders (SIMD), its stock has responded to both announcements with a strong leap.

April 12, 2022
·
2 min read
·
Jazmine Colatriano M.S.
Drug Development

Lilly Poised to Take on Competitors in Atopic Dermatitis

Eli Lilly has shared positive results of lebrikizumab combination therapy with topical corticosteroids, which is intended to treat atopic dermatitis (AD).

April 12, 2022
·
2 min read
·
Hayley Shasteen
BioMidwest

Bio-Techne and Cygnus Technologies, Part of Maravai Lifesciences, Introduce New Simple Plex HEK 293 HCP 3G Immunoassay

Bio-Techne Corporation and Cygnus Technologies, part of Maravai LifeSciences, announced the launch of the Simple Plex™ HEK 293 HCP 3G assay for automated process impurity testing on the Ella™ immunoassay platform.

April 12, 2022
·
4 min read
Drug Development

Cyclacel Pharmaceuticals Announces Publication Confirming Fadraciclib Suppresses MCL1 and Synergizes With Venetoclax in Chronic Lymphocytic Leukemia

Cyclacel Pharmaceuticals, Inc. today announced a publication in the journal Leukemia.

April 12, 2022
·
9 min read
Esaote S.p.A. turns 40 and is confirmed as a leading player in the world market for diagnostic imaging with ultrasound systems, magnetic resonance imaging and information technology for healthcare

Esaote S.p.A., a leading biomedical company in the diagnostic imaging sector - in the fields of ultrasound, magnetic resonance and Information Technology for health - celebrates forty years of activity.

April 12, 2022
·
2 min read
Business

Persephone Biosciences and Ginkgo Bioworks Announce Collaboration to Develop Novel Therapeutics

Persephone Biosciences Inc. and Ginkgo Bioworks today announced a collaboration to develop a novel therapeutics based on the bacterial genus Bacteroides.

April 12, 2022
·
5 min read
Business

Vedere Bio II Announces Appointment of Industry Veteran Gina Consylman as Chief Financial Officer

Vedere Bio II, Inc. today announced the appointment of Gina Consylman as Chief Financial Officer.

April 12, 2022
·
2 min read